Q1 Earnings Forecast for McKesson Issued By Leerink Partnrs

McKesson Corporation (NYSE:MCK) – Analysts at Leerink Partnrs reduced their Q1 2026 EPS estimates for McKesson in a note issued to investors on Tuesday, July 1st. Leerink Partnrs analyst M. Cherny now anticipates that the company will post earnings of $8.30 per share for the quarter, down from their previous estimate of $8.74. The consensus estimate for McKesson’s current full-year earnings is $32.77 per share. Leerink Partnrs also issued estimates for McKesson’s Q2 2026 earnings at $8.41 EPS, Q3 2026 earnings at $9.74 EPS and FY2026 earnings at $37.50 EPS.

A number of other research analysts also recently issued reports on the stock. Wells Fargo & Company set a $766.00 target price on shares of McKesson and gave the company an “equal weight” rating in a research report on Tuesday, June 3rd. UBS Group upped their price objective on shares of McKesson from $708.00 to $805.00 and gave the stock a “buy” rating in a research report on Tuesday, April 29th. Morgan Stanley upped their price objective on shares of McKesson from $745.00 to $770.00 and gave the stock an “overweight” rating in a research report on Wednesday, June 11th. Cfra Research downgraded shares of McKesson from a “moderate buy” rating to a “hold” rating in a research report on Friday, April 4th. Finally, Bank of America upped their price objective on shares of McKesson from $755.00 to $800.00 and gave the stock a “buy” rating in a research report on Friday, May 9th. Three equities research analysts have rated the stock with a hold rating, ten have assigned a buy rating and two have given a strong buy rating to the company. According to data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and a consensus price target of $696.42.

McKesson Price Performance

NYSE MCK opened at $719.30 on Thursday. The company has a market capitalization of $89.99 billion, a PE ratio of 27.85, a P/E/G ratio of 1.44 and a beta of 0.48. The company has a fifty day moving average of $714.17 and a 200 day moving average of $657.15. McKesson has a 1 year low of $464.42 and a 1 year high of $736.96.

McKesson (NYSE:MCK) last posted its earnings results on Thursday, May 8th. The company reported $10.12 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $9.83 by $0.29. The company had revenue of $90.82 billion during the quarter, compared to the consensus estimate of $94 billion. McKesson had a net margin of 0.92% and a negative return on equity of 201.12%. The firm’s quarterly revenue was up 18.9% on a year-over-year basis. During the same period in the previous year, the firm posted $6.18 earnings per share.

Hedge Funds Weigh In On McKesson

Institutional investors have recently modified their holdings of the company. Brighton Jones LLC increased its position in McKesson by 46.3% during the fourth quarter. Brighton Jones LLC now owns 2,523 shares of the company’s stock worth $1,438,000 after purchasing an additional 798 shares during the last quarter. Jones Financial Companies Lllp increased its position in McKesson by 31.8% during the fourth quarter. Jones Financial Companies Lllp now owns 6,655 shares of the company’s stock worth $3,793,000 after purchasing an additional 1,604 shares during the last quarter. SBI Securities Co. Ltd. acquired a new position in McKesson during the fourth quarter worth approximately $312,000. Steward Partners Investment Advisory LLC increased its position in McKesson by 10.3% during the fourth quarter. Steward Partners Investment Advisory LLC now owns 5,418 shares of the company’s stock worth $3,088,000 after purchasing an additional 506 shares during the last quarter. Finally, Commerzbank Aktiengesellschaft FI increased its position in McKesson by 22.5% during the fourth quarter. Commerzbank Aktiengesellschaft FI now owns 768 shares of the company’s stock worth $439,000 after purchasing an additional 141 shares during the last quarter. Institutional investors and hedge funds own 85.07% of the company’s stock.

Insiders Place Their Bets

In other news, CFO Britt J. Vitalone sold 1,878 shares of McKesson stock in a transaction dated Wednesday, May 28th. The shares were sold at an average price of $717.91, for a total value of $1,348,234.98. Following the sale, the chief financial officer owned 14,028 shares of the company’s stock, valued at $10,070,841.48. The trade was a 11.81% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, CAO Napoleon B. Rutledge, Jr. sold 543 shares of the business’s stock in a transaction dated Monday, May 19th. The stock was sold at an average price of $726.51, for a total transaction of $394,494.93. Following the sale, the chief accounting officer directly owned 1,972 shares in the company, valued at approximately $1,432,677.72. This represents a 21.59% decrease in their position. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 33,117 shares of company stock valued at $23,526,451. Corporate insiders own 0.08% of the company’s stock.

McKesson Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Tuesday, July 1st. Stockholders of record on Monday, June 2nd were issued a $0.71 dividend. This represents a $2.84 annualized dividend and a dividend yield of 0.39%. The ex-dividend date was Monday, June 2nd. McKesson’s payout ratio is 10.99%.

McKesson Company Profile

McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, Prescription Technology Solutions (RxTS), Medical-Surgical Solutions, and International. The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar and over-the-counter pharmaceutical drugs, and other healthcare-related products.